Results 41 to 50 of about 47,572 (272)

CAQ Corner: Basic concepts of transplant immunology

open access: yes, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Medication Complications in Extracorporeal Membrane Oxygenation. [PDF]

open access: yes, 2017
The need for extracorporeal membrane oxygenation (ECMO) therapy is a marker of disease severity for which multiple medications are required. The therapy causes physiologic changes that impact drug pharmacokinetics.
Aebi   +99 more
core   +2 more sources

Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris [PDF]

open access: yes, 2017
The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare–associated infections. We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive
Borman, Andrew   +6 more
core   +3 more sources

Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection [PDF]

open access: yesAmerican Journal of Respiratory and Critical Care Medicine, 2016
Contains fulltext : 166535.pdf (Publisher’s version ) (Open Access)
Kolwijck, E.   +8 more
openaire   +2 more sources

Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients

open access: yesClinical and Translational Science, 2021
Voriconazole is the mainstay for the treatment of invasive fungal infections in patients who underwent a kidney transplant. Variant CYP2C19 alleles, hepatic function, and concomitant medications are directly involved in the metabolism of voriconazole ...
Yi‐Chang Zhao   +9 more
doaj   +1 more source

Impact of extracorporeal membrane oxygenation on voriconazole plasma concentrations: A retrospective study

open access: yesFrontiers in Pharmacology, 2022
Aims: We aimed to assess the impact of extracorporeal membrane oxygenation (ECMO) on voriconazole exposure.Methods: Adult critically ill patients with or without ECMO support receiving intravenous voriconazole therapy were included in this retrospective ...
Qinghua Ye   +11 more
doaj   +1 more source

Voriconazole-induced periostitis [PDF]

open access: yesCanadian Medical Association Journal, 2015
A 66-year-old woman with a two-year history of T-cell prolymphocytic leukemia presented with left shoulder pain of 10 months’ duration. A month before the admission, the pain became severe, constant and disabling.
Ines Colmegna, Tetiana Glushko
openaire   +3 more sources

Evaluation of the interaction of intravenous and oral voriconazole with oral cyclosporine in iranian HSCT patients

open access: yesJournal of Research in Pharmacy Practice, 2017
Objective: Voriconazole as a triazole antifungal agent is widely used for prophylaxis or treatment of fungal infections in allogeneic hematopoietic stem cell transplantation (HSCT).
Hamidreza Taghvaye Masoumi   +3 more
doaj   +1 more source

Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report. [PDF]

open access: yes, 2021
It is not yet known, if critically ill COVID-19 patients are prone to fungal infections. We report a 69-year-old patient without typical risk factors for invasive pulmonary aspergillosis (IPA), who developed IPA two weeks after onset of symptoms.
Eller, Philipp   +5 more
core  

Combined Effect of CYP2C19 Genetic Polymorphisms and C-Reactive Protein on Voriconazole Exposure and Dosing in Immunocompromised Children

open access: yesFrontiers in Pediatrics, 2022
BackgroundPediatric patients have significant interindividual variability in voriconazole exposure. The aim of the study was to identify factors associated with voriconazole concentrations and dose requirements to achieve therapeutic concentrations in ...
Juan Chen   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy